Members of an advisory panel have proposed adding warning labels to some medication about adverse maternal and fetal risks in ...

The Food and Drug Administration is considering adding warning labels to antidepressants for people who are pregnant, despite ...

On Monday morning, the FDA hosted a 10-person expert panel on the use during pregnancy of SSRIs, which include medications ...

The president of the American College of Obstetricians and Gynecologists said the claims were "outlandish and unfounded" and will "only serve to incite fear." ...

Members of an advisory panel have proposed adding warning labels to some medication about adverse maternal and fetal risks in ...

Pregnancy presents a unique ethical dilemma. The unborn child cannot give consent, and damage sustained in the womb can ...

Members of an FDA expert panel discussed the risks and benefits of selective serotonin reuptake inhibitors, or SSRIs, for ...

Doctors on Monday urged the U.S. Food and Drug Administration to issue warnings to pregnant women against the use of certain ...

An agency-sponsored forum included critics of psychiatry who believe the drugs can harm a developing fetus. Other experts said antidepressants were safe and necessary.

Experts on the panel shared many of the same views around SSRIs, arguing the risks of the drugs during pregnancy are greater than currently accepted.

On July 21, the US Food and Drug Administration (FDA) convened a 10-expert panel to determine whether women should be warned about the potential dangers to their baby if they take antidepressants like ...

An unusual FDA panel on antidepressant use during pregnancy elevated clinicians and researchers who are deeply skeptical of ...